Enrolling by invitationNot applicableNCT06235632

Responsible Marijuana Sales Practices to Reduce the Risk of Selling to Intoxicated Customers

Studying Oculocerebral hypopigmentation syndrome, Cross type

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Klein Buendel, Inc.
Principal Investigator
Gill Woodall, PhD
Klein Buendel, Inc.
Intervention
Policy and Training Intervention(behavioral)
Enrollment
229 enrolled
Eligibility
21 years · All sexes
Timeline
20242027

Study locations (1)

Collaborators

National Institute on Alcohol Abuse and Alcoholism (NIAAA) · Pacific Institute for Research and Evaluation · National Opinion Research Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06235632 on ClinicalTrials.gov

Other trials for Oculocerebral hypopigmentation syndrome, Cross type

Additional recruiting or active studies for the same condition.

See all trials for Oculocerebral hypopigmentation syndrome, Cross type

← Back to all trials